journal article·2026-04Open access

Hepatocyte growth factor in biosheets promotes autonomous regeneration of cutaneous tissue after transplantation onto a full-thickness skin defect

Keisuke Suzuki, Hiroko Komura, Ryo Konno, Yusuke Kawashima, Eiichiro Watanabe, Hiroki Sato, Kunio Matsumoto, Ryoko Inaki, Sanshiro Kanazawa, Yukiyo Asawa, Atsuhiko Hikita, Kazuto Hoshi, Jun Fujishiro, Makoto Komura

Abstract

Biosheets and biotubes are collagenous connective tissue membranes that surround unabsorbable molds embedded in living tissues, and can regenerate damaged tissues in various organs following in-situ transplantation. However, the mechanisms underlying tissue regeneration are still unclear. In this study, we analyzed the histological features and cellular composition in the biosheets, and observed dramatic time-dependent changes. We transplanted biosheets into full-thickness wounds in a mouse model, and evaluated skin regeneration through histological analysis in comparison with subcutaneous fascia transplantation. Our findings confirm that biosheets can accelerate epithelialization of skin wounds of mouse more effectively than fascia. To elucidate the mechanism underlying skin regeneration by biosheets, we compared the protein expression in the biosheets and subcutaneous fascia. Proteomics analysis revealed significant differences in the protein profiles of the biosheets and fascia, with marked elevation of hepatocyte growth factor (HGF) in the biosheets. Addition of HGF in situ accelerated angiogenesis and epithelial regeneration in the fascia-transplanted full-thickness wounds in mice. On the other hand, neutralization of HGF impaired the wound healing process following biosheet transplantation. In conclusion, our findings suggest that HGF mediates biosheet-mediated regeneration of cutaneous tissues by contributing to re-epithelialization and angiogenesis. • Biosheets have been investigated as scaffolds for cutaneous tissue regeneration. • Biosheets accelerated cutaneous regeneration in a mouse model. • Proteomic analysis of biosheets showed elevation of HGF, PDGF-β, TGF-β, and Cdk1. • Neutralization of HGF in biosheets by anti-HGF antibodies impaired cutaneous regeneration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Liver physiology and pathology · Wound Healing and Treatments · Corneal Surgery and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (91)

Show source-provided references
1. The pathology of the foreign body reaction against biomaterials10.1002/jbm.a.35958 ↗
2. The foreign body response: at the interface of surgery and bioengineering10.1097/PRS.0000000000001193 ↗
3. In vivo tissue-engineered small-caliber arterial graft prosthesis consisting of autologous tissue (biotube)10.3727/000000004783983828 ↗
4. Implantation study of small-caliber “biotube” vascular grafts in a rat model10.1007/s10047-012-0676-y ↗
5. Architecture of an in vivo-tissue engineered autologous conduit “Biovalve”10.1002/jbm.b.30981 ↗
6. Patch tracheoplasty in body tissue engineering using collagenous connective tissue membranes (biosheets)10.1016/j.jpedsurg.2015.10.068 ↗
7. In-body tissue-engineered collagenous connective tissue membranes (BIOSHEETs) for potential corneal stromal substitution10.1002/term.1859 ↗
8. Autologous small-caliber “biotube” vascular grafts with argatroban loading: a histomorphological examination after implantation to rabbits10.1002/jbm.b.31510 ↗
9. Development of long in vivo tissue-engineered “Biotube” vascular grafts10.1016/j.biomaterials.2018.09.032 ↗
10. Development of in vivo tissue-engineered microvascular grafts with an ultra small diameter of 0.6 mm (MicroBiotubes): acute phase evaluation by optical coherence tomography and magnetic resonance angiography10.1007/s10047-016-0894-9 ↗
11. One year rat study of iBTA-induced “microbiotube” microvascular grafts with an ultra-small diameter of 0.6 mm10.1016/j.ejvs.2018.03.011 ↗
12. Development of an in vivo tissue-engineered vascular graft with designed wall thickness (biotube type C) based on a novel caged mold10.1007/s10047-015-0859-4 ↗
13. Wall thickness control in biotubes prepared using type-C mold10.1007/s10047-018-1035-4 ↗
14. Long-term animal implantation study of biotube-autologous small-caliber vascular graft fabricated by in-body tissue architecture10.1002/jbm.b.31841 ↗
15. First successful clinical application of the in vivo tissue-engineered autologous vascular graft10.1016/j.athoracsur.2016.06.095 ↗
16. Initial 3-year results of first human use of an in-body tissue-engineered autologous "biotube" vascular graft for hemodialysis10.1177/1129729819852550 ↗
17. Patch esophagoplasty using an in-body-tissue-engineered collagenous connective tissue membrane10.1016/j.jpedsurg.2017.11.004 ↗
18. A new method of primary engineering of esophagus using orthotopic in-body tissue architecture10.1016/j.jpedsurg.2021.03.025 ↗
19. Urinary bladder reconstruction using autologous collagenous connective tissue membrane "biosheet(R)" induced by in-body tissue architecture: a pilot study10.1016/j.reth.2020.10.006 ↗
20. iBTA-induced bovine biosheet for repair of abdominal wall defects in a beagle model: proof of concept10.1007/s10029-018-1799-8 ↗
21. One-year follow-up study of iBTA-induced allogenic biosheet for repair of abdominal wall defects in a beagle model: a pilot study10.1007/s10029-018-1866-1 ↗
22. Fabrication of an anatomy-mimicking BIO-AIR-TUBE with engineered cartilage10.1016/j.reth.2019.07.004 ↗
23. Engineering and repair of diaphragm using biosheet (a collagenous connective tissue membrane) in rabbits10.1016/j.jpedsurg.2017.11.035 ↗
24. Skin wound healing process and new emerging technologies for skin wound care and regeneration10.3390/pharmaceutics12080735 ↗
25. Tissue engineering of skin for wound coverage10.1055/s-0033-1352529 ↗
26. Current regenerative medicine-based approaches for skin regeneration: a review of literature and a report on clinical applications in Japan10.1016/j.reth.2022.05.008 ↗
27. Regeneration of the entire human epidermis using transgenic stem cells10.1038/nature24487 ↗
28. Engineering of a decellularized bovine skin coated with antibiotics-loaded electrospun fibers with synergistic antibacterial activity for the treatment of infectious wounds10.1002/bit.28659 ↗
29. Engineering of a bilayer film made from decellularized amniotic membrane and emulsion for skin tissue engineering applications10.1002/pat.70247 ↗
30. Fabrication and characterization of a hydrocolloid wound dressing functionalized with human placental derived extracellular matrix for management of skin wounds: an animal study10.1111/aor.14674 ↗
31. Snail-inspired AFG/GelMA hydrogel accelerates diabetic wound healing via inflammatory cytokines suppression and macrophage polarization10.1016/j.biomaterials.2023.122141 ↗
32. Evaluation of skin wound healing with biosheets containing somatic stem cells in a dog model: a pilot study10.3390/bioengineering11050435 ↗
33. Dramatic wound closing effect of a single application of an iBTA-Induced autologous biosheet on severe diabetic foot ulcers involving the heel area10.3390/bioengineering11050462 ↗
34. Involvement of somatic stem cells in encapsulation of foreign-body reaction in canine subcutaneous biotube tissue formation10.1016/j.jbiosc.2021.07.003 ↗
35. Mesenchymal stem cells: cell therapy and regeneration potential10.1002/term.2914 ↗
36. Furnishing wound repair by the subcutaneous fascia10.3390/ijms22169006 ↗
37. Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT(R)) mesenchymal Stromal Cell committee position statement on nomenclature10.1016/j.jcyt.2019.08.002 ↗
38. Positional identity of murine mesenchymal stem cells resident in different organs is determined in the postsegmentation mesoderm10.1089/scd.2011.0551 ↗
39. Isolation and characterization of lung resident mesenchymal stem cells capable of differentiating into alveolar epithelial type II cells10.1002/cbin.10240 ↗
40. Optimal Sca-1-based procedure for purifying mouse adipose-derived mesenchymal stem cells with enhanced proliferative and differentiation potential10.3389/fcell.2025.1566670 ↗
41. Murine mesenchymal stromal cells retain biased differentiation plasticity towards their tissue of origin10.3390/cells9030756 ↗
42. Multi-omics "upstream analysis" of regulatory genomic regions helps identifying targets against methotrexate resistance of colon cancer10.1016/j.euprot.2016.09.002 ↗
43. Biology and therapeutic potential of interleukin-1010.1084/jem.20190418 ↗
44. TGF-beta signaling in health and disease10.1016/j.cell.2023.07.036 ↗
45. Roles of PDGF/PDGFR signaling in various organs10.4196/kjpp.24.309 ↗
46. Cell cycle-dependent transcription: the cyclin dependent kinase Cdk1 is a direct regulator of basal transcription machineries10.3390/ijms23031293 ↗
47. Hepatocyte growth factor twenty years on: much more than a growth factor10.1111/j.1440-1746.2010.06549.x ↗
48. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor, vascul
49. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease10.1038/sj.gt.3301379 ↗
50. Recombinant human hepatocyte growth factor plasmids for treating patients with chronic limb threatening ischaemia: a systematic review and meta-analysis10.1016/j.ejvs.2024.07.016 ↗
51. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury10.1002/jnr.21372 ↗
52. Phase I/II study of intrathecal administration of recombinant human hepatocyte growth factor in patients with acute spinal cord injury: a double-blind, randomized clinical trial of safety and efficacy10.1089/neu.2019.6854 ↗
53. Diverse and potent activities of HGF/SF in skin wound repair10.1002/path.1578 ↗
54. Neutralization of hepatocyte growth factor leads to retarded cutaneous wound healing associated with decreased neovascularization and granulation tissue formation10.1046/j.1523-1747.2003.12039.x ↗
55. Dried human cultured epidermis accelerates wound healing in diabetic mouse skin defect wounds10.1038/s41598-022-07156-w ↗
56. MSC-EVs and UCB-EVs promote skin wound healing and spatial transcriptome analysis10.1038/s41598-025-87592-6 ↗
57. HGF/c-Met axis: the advanced development in digestive system cancer10.3389/fcell.2020.00801 ↗
58. Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies10.1038/s41392-025-02313-9 ↗
59. Stem cell-based therapy for pulmonary fibrosis10.1186/s13287-022-03181-8 ↗
60. Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis
61. Mesenchymal stem cell-based immunomodulation: properties and clinical application
62. A phase 3, single-arm, prospective study of Remestemcel-L, Ex vivo culture-expanded adult human mesenchymal stromal cells for the treatment of pediatric patients who failed to respond to steroid treatment for acute graft-versus-host disease10.1016/j.bbmt.2020.01.018 ↗
63. Efficacy of mesenchymal stem cell-based therapies in the treatment of perianal fistulizing Crohn's disease: a systematic review and meta-analysis10.1186/s13287-025-04272-y ↗
64. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial10.1186/s13287-022-02941-w ↗
65. The promise of cell-based therapies in diabetes: a review of mesenchymal stem cell applications and trials10.1016/j.biochi.2025.07.011 ↗
66. Mesenchymal stem cell therapy in multiple sclerosis: a systematic review and meta-analysis10.3390/jcm12196311 ↗
67. Paracrine factors released by stem cells of mesenchymal origin and their effects in cardiovascular disease: a systematic review of pre-clinical studies10.1007/s12015-022-10429-6 ↗
68. Hepatocyte growth factor facilitates the repair of spinal cord injuries by driving the chemotactic migration of mesenchymal stem cells through the beta-catenin/TCF4/Nedd9 signaling pathway10.1093/stmcls/sxae055 ↗
69. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury10.1186/s13287-019-1488-2 ↗
70. In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair10.1126/sciadv.aay6994 ↗
71. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils10.1182/blood.V99.8.2997 ↗
72. Hepatocyte growth factor in polymorphonuclear leukocytes is increased in patients with systemic inflammatory response syndrome10.1097/01.TA.0000111752.60500.DA ↗
73. Tumor-neutrophil cross talk orchestrates the tumor microenvironment to determine the bladder cancer progression10.1073/pnas.2312855121 ↗
74. CD177(+) neutrophils drive extracellular matrix remodelling and HGF-alpha release in ALPPS-induced liver regeneration10.1136/gutjnl-2025-336300 ↗
75. A simple and effective flow cytometry-based method for identification and quantification of tissue infiltrated leukocyte subpopulations in a mouse model of peripheral arterial disease10.3390/ijms21103593 ↗
76. Optimized flow cytometry assays to monitor neutrophil activation in human and mouse whole blood samples10.1016/j.jim.2022.113403 ↗
77. Labelling of rat endothelial cells with antibodies to vWF, RECA-1, PECAM-1, ICAM-1, OX-43 and ZO-110.1046/j.1439-0264.2002.00357.x ↗
78. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues10.1369/jhc.4A6514.2005 ↗
79. Most important biomedical and pharmaceutical applications of silicones10.3390/ma18112561 ↗
80. Ultrasound-guided percutaneous insertion of Broviac lines in infants less than 5kg: prospective study of 100 consecutive procedures10.1016/j.jpedsurg.2022.01.005 ↗
81. Ultrasensitive proteome analysis using paramagnetic bead technology10.15252/msb.20145625 ↗
82. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments10.1038/s41596-018-0082-x ↗
83. Improving precursor selectivity in data-independent acquisition using overlapping windows10.1007/s13361-018-2122-8 ↗
84. Single-shot 10K proteome approach: over 10,000 protein identifications by data-independent acquisition-based single-shot proteomics with ion mobility spectrometry10.1021/acs.jproteome.2c00023 ↗
85. Development of a simple and stable NanoESI spray system using suction wind from the MS inlet10.1021/acs.jproteome.3c00146 ↗
86. Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning10.1038/s41592-019-0426-7 ↗
87. Generating high quality libraries for DIA MS with empirically corrected peptide predictions10.1038/s41467-020-15346-1 ↗
88. The perseus computational platform for comprehensive analysis of (prote)omics data10.1038/nmeth.3901 ↗
89. Purification and subunit structure of hepatocyte growth factor from rat platelets10.1016/0014-5793(87)80475-1 ↗
90. Molecular cloning and expression of human hepatocyte growth factor10.1038/342440a0 ↗
91. Suppression of acute hepatic injury by a synthetic prostacyclin agonist through hepatocyte growth factor expression10.1152/ajpgi.00216.2011 ↗